“FDA Advisory Committee To Review Human Genome Sciences’ Anthrax Treatment” (The Pink Sheet)
Human Genome Sciences’ anthrax treatment ABthrax (raxibacumab), which has already been sold to the U.S. government, is moving through the final review process at FDA.
This is copyright protected information, to receive the full article, please click here to sign up and register.
“Larry D’Andrea Joins Spartan Bioscience as CEO” (News Blaze)
“Don’t count on a bid for AstraZeneca” (City Wire)
“Ohio State To Pioneer National Genome Study” (Media Newswire)
“Flu Season Off And Running: Illnesses already at December, January levels, officials say” (Individual)
“FDA needs more time to complete review on GSK’s Cervarix” (PharmaTimes)
“Novartis plans to file oral MS drug by the end of the year” (PharmaTimes)
SUBSCRIBE